Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Lago

Alfredo Iglesias Lago, Vedra ES

Patent application numberDescriptionPublished
20100258732Neutron dosimetry for radiotherapy - A system includes emission of a first treatment beam associated with a first energy toward a neutron dose detector, determination of a first number of soft errors experienced by a semiconductor-based device exposed to neutrons generated by the first treatment beam, determination of a first neutron dose based on the first treatment beam using the neutron dose detector, and association of the first energy of the first treatment beam with the first number of soft errors and the first neutron dose. Some aspects include emission of a second treatment beam associated with the first energy toward a target, determination of a second number of soft errors experienced by the semiconductor-based device exposed to neutrons generated by the second treatment beam, and determination of a second neutron dose at the target based on the association between the first energy, the first number of soft errors and the first neutron dose.10-14-2010

Andre Lago, Hamburg DE

Patent application numberDescriptionPublished
20100324336PROCESS FOR THE PRODUCTION OF AROMATIC AMINES - Aromatic amines produced by hydrogenation of the corresponding nitroaromatic compounds are purified in a specified manner. In the purification procedure, the particular amine is initially mixed with an aqueous solution of a base. The organic and aqueous phases are then separated by adding excess water.12-23-2010

Andre Lago, Minghang District CN

Patent application numberDescriptionPublished
20080234518Process for producing aromatic amines - Aromatic amines are produced by adiabatic hydrogenation of nitroaromatic compounds in the gas phase on one or more fixed catalysts. The nitroaromatic reactant is passed over the catalyst under pressure and at elevated temperature with hydrogen, water, optionally nitrogen and substantially in the absence of the aromatic amine produced from the nitroaromatic.09-25-2008

Brenton Lago, Las Vegas, NV US

Patent application numberDescriptionPublished
20090155429Food Package - Disclosed is a food package used for consumption by a patient who has undergone a weight-loss surgery. The food package includes a food product in a frozen form and a container for storing the food product. The food package further includes an air tight seal configured on the container for retaining the food product stored inside the container. The food product may weigh less than or equal to about four ounces. The food product disclosed herein may be consumed as a healthy, balanced meal.06-18-2009

Firmin Lago, Milwaukee, WI US

Patent application numberDescriptionPublished
20100284981MICROORGANISMS AND METHODS FOR TREATING POULTRY - An isolated 11-11-2010

Leopoldo Lago, Cittadella IT

Patent application numberDescriptionPublished
20110297513Bar conveyor belt, particularly for the food industry - A bar conveyor belt includes two parallel longitudinal chains and a plurality of bars forming the conveying surface and fixed at their ends to the successive links of the two chains. Each chain link consists of a metal plate bent in the form of a U with its arms disposed to define a space intended to partially house that adjacent link positioned upstream with reference to the chain advancement direction, the arms being provided with a longitudinal slot for passage of that bar connected to the downstream link, the outer arm presenting an appendix engageable by the teeth of a drive sprocket. The appendix of each link is bent in the chain advancement direction to form a tooth with a complete involute profile, and the end of each bar extends into the appendix and is fixed to the top thereof, after passing through two holes provided in the arms of the link and the slots provided in the arms of the upstream link.12-08-2011

Santiago Lago, Malaga ES

Patent application numberDescriptionPublished
20100298255Methods for providing personalized medicine test ex vivo for hematological neoplasms - Described herein are methods, devices, and compositions for providing personalized medicine tests for hematological neoplasms. In some embodiments, the methods comprise measuring the efficacy of inducing apoptosis selectively in malignant cells using any number of potential alternative combination drug treatments. In some embodiments, the ex vivo testing is measured using a recently extracted patient hematological samples. In other embodiments, the efficacy is measured ex vivo using an automated flow cytometry platform. For example, by using an automated flow cytometry platform, the evaluation of hundreds, or even thousands of drugs and compositions, can be made ex vivo. Thus, alternative polytherapy treatments can be explored. Non-cytotoxic drugs surprisingly induce apoptosis selectively in malignant cells ex vivo. In some embodiments, the methods described herein comprise evaluating non-cytotoxic drugs.11-25-2010